WT
REGN icon

Wilmington Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Wilmington Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$1.83M Buy
6,487
+4,292
+196% +$1.27M 0.03% 279
2014
Q1 		$659K Buy
2,195
+280
+15% +$86.3K 0.01% 447
2013
Q4 		$528K Buy
1,915
+143
+8% +$41.1K 0.01% 494
2013
Q3 		$554K Sell
1,772
-2,650
-60% -$697K 0.01% 470
2013
Q2 		$994K Buy
+4,422
New +$1.03M 0.02% 321

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Trust's REGN Position: Q2 2014 in Review

Wilmington Trust increased its Regeneron Pharmaceuticals (REGN) stake by 196% in Q2 2014, buying an estimated $1.27M and bringing the position to 6,487 shares worth $1.83M. The position accounts for 0.03% of the portfolio, ranked #279.

Wilmington Trust first reported a position in REGN in Q2 2013 and has held it in 5 quarters since. 448 funds tracked by Wall St. Rank hold REGN as of Q2 2014.

  • Wilmington Trust held 6,487 shares of Regeneron Pharmaceuticals worth $1.83M as of Q2 2014.
  • Wilmington Trust bought 4,292 Regeneron Pharmaceuticals shares in Q2 2014, an estimated $1.27M.
  • Regeneron Pharmaceuticals made up 0.03% of Wilmington Trust's portfolio in Q2 2014, its #279 holding.
  • Wilmington Trust first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
  • 448 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.